Related Links:

Background: Knee replacement typically results in reduced pain and improved function, but it is unclear if these improvements lead to weight loss.
Objective: The purpose of this study was to examine weight change patterns preoperatively and postoperatively among overweight/obese knee replacement patients.
Methods: The study evaluated 210 overweight/obese patients from the Osteoarthritis Initiative who underwent a knee replacement during an 8-year longitudinal study. Average annual weight changes during 1- to 2-year intervals prior to, including, and subsequent to knee replacement were categorized as loss (≥−2.5%...

Background:A high proportion of type 2 diabetes cases are associated with host genetic and environmental factors. During the past decade, microorganisms that inhabit the gut have emerged as contributors to the pathogenesis of obesity and type 2 diabetes. Therefore, manipulation of the human gut microbiota will provide essential clues regarding new therapeutic targets for diabetes.Summary:Several studies have established the presence of gut dysbiosis in patients with type 2 diabetes mellitus, even though there are some differences among the studies that could be explained by differences in ethnicity, diet, and methodology. ...

Summary
Emerging research suggests that rates of food addiction are high among individuals seeking bariatric surgery, but little is known about associated features and the prognostic significance of pre‐operative food addiction. Thus, this article provides a systematic review and synthesis of the literature on food addiction and bariatric surgery. Articles were identified through PubMed and SCOPUS databases, resulting in a total of 19 studies which assessed food addiction among pre‐bariatric and/or post‐bariatric surgery patients using the Yale Food Addiction Scale. Most studies were cross‐sectional, and only two s...

This study is useful on many levels. It shows continued evidence of EndoBarrier efficacy across multiple health metrics, including standard blood sugar and weight metrics, as well as insulin sensitivity, fasting glucose, and key inflammatory mediators,” GI Dynamics president and CEO Scott Schorer said in the statement. “The study also presents early data indicating that EndoBarrier produces clinical efficacy that is on par with and in some cases superior to surgical gastric plication, which is a restrictive bariatric surgery. The fact that these results can be achieved in a minimally invasive treatment with End...